1. Atrial Fibrillation and Acute Myocardial Infarction: Antithrombotic Therapy and Outcomes 
Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B. Granger, MD, Tracy Y. Wang, MD, MHS, MSc, JoAnne M. Foody, MD, Marjorie Funk, PhD, RN, Eric D. Peterson, MD, MPH, Karen P. Alexander, MD 
The American Journal of Medicine 
Volume 125, Issue 9, Pages (September 2012)
DOI: /j.amjmed
Copyright © 2012 Elsevier Inc. Terms and Conditions

2. Figure 1
Use of discharge antithrombotic therapy among patients with atrial fibrillation by CHADS2 score. CHADS2=Congestive heart failure, Hypertension, Age, Diabetes, Stroke (Doubled).
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © 2012 Elsevier Inc. Terms and Conditions

3. Figure 2
Use of discharge antithrombotic therapy among patients with atrial fibrillation by bleeding score at discharge.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © 2012 Elsevier Inc. Terms and Conditions

4. Figure 3
Use of discharge warfarin and triple therapy among patients with atrial fibrillation according to CHADS2 score. CHADS2=Congestive heart failure, Hypertension, Age, Diabetes, Stroke (Doubled).
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © 2012 Elsevier Inc. Terms and Conditions